Literature DB >> 22292364

[Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital].

Xuelin Li1, Jinfa Tang, Fei Meng, Chunxiao Li, Yanming Xie.   

Abstract

OBJECTIVE: To study Danhong injection adverse reactions (ADR) incidence, nature and clinical performance, provide the basis for the clinical safety of drugs.
METHOD: Multi-center, a large sample of hospitals focused on monitoring method. RESULT: Danhong injection ADR for the rapid onset and ease the quick recovery, the rate was 0. 682% , the newly discovered ADR constipation, sweating, tinnitus, irritability, joint disease, erythema, venous pain, phlebitis, local numbness, pain, weakness, gastrointestinal ulcer bleeding, vasospasm, cyanosis.
CONCLUSION: Danhong injection adverse reactions are type A adverse reactions occasionally, centralized monitoring of hospital medicine injection method is to carry out post-marketing safety re-evaluation of appropriate methods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22292364

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Quantitative profiling of polar metabolites in herbal medicine injections for multivariate statistical evaluation based on independence principal component analysis.

Authors:  Miaomiao Jiang; Yujiao Jiao; Yuefei Wang; Lei Xu; Meng Wang; Buchang Zhao; Lifu Jia; Hao Pan; Yan Zhu; Xiumei Gao
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

2.  Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury.

Authors:  Shaoxia Wang; Hong Guo; Xumei Wang; Lijuan Chai; Limin Hu; Tao Zhao; Buchang Zhao; Xiaoxu Tan; Feifei Jia
Journal:  Neural Regen Res       Date:  2014-08-01       Impact factor: 5.135

3.  Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.

Authors:  Chunxiao Li; Tao Xu; Peng Zhou; Junhua Zhang; Ge Guan; Hui Zhang; Xiao Ling; Weixia Li; Fei Meng; Guanping Liu; Linyan Lv; Jun Yuan; Xuelin Li; Mingjun Zhu
Journal:  BMC Complement Altern Med       Date:  2018-10-16       Impact factor: 3.659

4.  Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.

Authors:  Bing Li; Yilong Wang; Jingjing Lu; Jun Liu; Ye Yuan; Yanan Yu; Pengqian Wang; Xingquan Zhao; Zhong Wang
Journal:  Trials       Date:  2015-12-09       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.